Key Takeaways
- • Venture Investors Health Fund ("VI") announced the close of its seventh fund at $80 million, according to a Business Wire release dated September 9, 2025.
- • The fund will back early-stage healthcare companies aiming to fundamentally change the standard of care, with a focus on precision, personalized care, improved access, and lower costs.
- • VI, a Midwest-based firm with a 40-year track record, has invested in more than 40 university ecosystem spinouts, including from the University of Wisconsin-Madison and the University of Michigan.
- • The firm's portfolio spans more than 80 companies, 11 of which have exited at valuations between $250 million and $2.25 billion.
- • Managing Partner Jim Adox said the fund will focus exclusively on technology that transforms how patients receive care, across medical devices, diagnostics, digital health, and pharma.
Summary
Venture Investors Health Fund (VI) has closed its seventh fund with $80 million in commitments, according to a Business Wire announcement. The fund is intended to back early-stage healthcare companies whose technologies could fundamentally change the standard of care, emphasizing more precise and personalized treatment, better access to care, and reduced costs. Managing Partner Jim Adox said the firm aims to accelerate the translation of decades of research into real-world patient impact.
VI describes itself as one of the Midwest's longest-tenured healthcare-focused venture capital firms, with a 40-year track record. The firm states it invests exclusively in innovations that can redefine care pathways rather than incrementally improve them. Cited portfolio examples include EarliTec, which has developed an objective eye-tracking method to diagnose autism, and HistoSonics, which uses sound energy to noninvasively destroy tumors. VI also reports having invested in more than 40 university ecosystem spinouts, including from the University of Wisconsin-Madison and the University of Michigan.
The firm is founded in the 1980s and has backed more than 80 companies, 11 of which have exited with valuations between $250 million and $2.25 billion. Named past investments include ThirdWave Technologies, TomoTherapy, IntraLase, Neurovance, NeuWave Medical, and LenSx Lasers. VI plans to deepen partnerships across Midwest markets including Minneapolis, Madison, Milwaukee, and Ann Arbor, and cites proximity to academic centers and healthcare companies such as Epic, GE, and Exact Sciences as an advantage. Kelly Sexton, Associate Vice President for Research - Innovation Partnerships and Economic Impact at the University of Michigan, praised the firm's collaboration with academic innovators.
VI describes itself as one of the Midwest's longest-tenured healthcare-focused venture capital firms, with a 40-year track record. The firm states it invests exclusively in innovations that can redefine care pathways rather than incrementally improve them. Cited portfolio examples include EarliTec, which has developed an objective eye-tracking method to diagnose autism, and HistoSonics, which uses sound energy to noninvasively destroy tumors. VI also reports having invested in more than 40 university ecosystem spinouts, including from the University of Wisconsin-Madison and the University of Michigan.
The firm is founded in the 1980s and has backed more than 80 companies, 11 of which have exited with valuations between $250 million and $2.25 billion. Named past investments include ThirdWave Technologies, TomoTherapy, IntraLase, Neurovance, NeuWave Medical, and LenSx Lasers. VI plans to deepen partnerships across Midwest markets including Minneapolis, Madison, Milwaukee, and Ann Arbor, and cites proximity to academic centers and healthcare companies such as Epic, GE, and Exact Sciences as an advantage. Kelly Sexton, Associate Vice President for Research - Innovation Partnerships and Economic Impact at the University of Michigan, praised the firm's collaboration with academic innovators.
Go deeper than the headline
Research every firm in this story, track the ones that matter and get the daily briefing — free for 7 days.